A B S T R A C T The characteristics of the disappearance of radioiodinated synthetic human calcitonin from plasma have been studied in man. After single injection the disappearance curve was multiexponential. The number of exponentials of the theoretical curve fitting the best with the experimental data varied individually. Metabolic clearance rate was determined both from single injection and constant infusion studies, and fast initial distribution volume from the former. Metabolic clearance rate values in normal man calculated from constant infusion studies were 82.3 ±3.4 ml/min per m'. Values derived from single injection studies were similar, 77.0 +-4.7 ml/min per m'. These results were compared to those obtained in end stage, renal failure patients. Metabolic clearance rate was considerably lower and volume of fast initial distribution slightly larger in that group. This fact emphasizes the important role of kidneys in the utilization and/or the degradation of human calcitonin.
INTRODUCTION
Studies of the metabolism of iodine-labeled human calcitonin (HCT) have been made possible by the use of synthetic human calcitonin (1) . In this report we discuss the results of studies of calcitonin metabolism in two groups of patients, normal subjects and uremic patients with nonfunctioning kidneys, the latter group being considered of interest in view of the role of the kidneys in the utilization and degradation of polypeptide hormones (2, 3) . Single injection and constant infusion techniques were used to calculate metabolic clearance rate (MCR) (4) . The results indicate a good agreement between the two methods. Considerably lower values were found in uremic subjects. METHODS
Subjects
An informed consent was obtained from all the subjects prior to studies. 13 subjects with normal renal function and without any evidence of disorders of calcium metabolism were studied. They were compared with 13 uremic patients in end stage renal failure treated by chronic hemodialysis. In the latter patients, the tests were always performed immediately prior to hemodialysis. One of them (LOY . . .) had had bilateral nephrectomy. The mean values of urea, calcium, and phosphorus concentration for each group are indicated on Table I .
Iodination
Synthetic HCT was kindly supplied by Ciba Ltd., Basel, Switzerland. Iodination was performed with 125-iodine (Amersham Radiochemical Centre) according to the Hunter and Greenwood method (5) with minor modifications. Separation of iodide and damaged components from pure '2I-HCT was done by QU SO G 321 microfine granules of precipitated silicates (6) . Efficiency of iodination and specific activity of 'I-HCT were calculated from chromatoelectrophoresis strips according to the method of Berson and Yalow (7) . Specific radioactivities were from 70 to 228 /LCi/Ihg (mean = 123 juCi//Ag). The same chromatoelectrophoretic method was used to estimate damage of the purified 'I-HCT which never exceeded 10%.
Experimental protocol
The tracer was stored at -20'C and used within 1 wk of iodination. Each batch was tested for sterility by standard bacteriological techniques before its use. 20-100,Ci (0.16-0.82 jtg) of 'I-HCT was administered into an antecubital vein in normal subjects and into the venous side of the brachial arteriovenous fistula in hemodialyzed subjects. In the single injection studies, the cannula was flushed with 1Philadelphia Quartz Co., Philadelphia, Pa. 22 25 obtained only after 6 hr of infusion. Blood samples were taken into disposable syringes containing 100 U of sodium heparin and kept in ice. Samples were centrifuged within 1 hr at +40C, and the plasma was separated.
Analysis of plasma hormone
The total radioactivity of a 1 ml sample of plasma was determined in an automatic gamma counter (NuclearChicago Corp., Des Plaines, Ill. '1I-HCT was measured by the following methods: (a) precipitation from 1 ml of plasma immediately after the centrifugation with 2 ml of cold 10% trichloracetic acid (TCA) with two further washings, and (b) chromatoelectrophoresis. Separation of pure '"I-HCT remaining at the origin from damaged products and iodine was performed on Whatman 3 M C strip (46 cm X 2.5 cm) in 0.05 M veronal buffer, pH 8.6. 100-,Al duplicates of each sample were run at constant voltage (500 v) for 1H hr. After the separation conditions had been established, the strips were divided into two parts from 0 to 8 cm and from 8 to 25 cm. This enabled the recovery of 100%o of the applied radioactivity and the separation of 'I-HCT which remains at the origin from damaged components which move behind the albumin and from iodide which moves in advance of the serum albumin. In each test, the strips obtained from the initial and final samples were cut every 2 cm in order to obtain a more complete plot of the radioactivity curve against the length of the strips. A good separation of radioactive calcitonin by using the 0-8 cm portion of the strip was confirmed on all occasions (Fig. 1 ).
Calculation and computational methods
For all calculations of MCR, the administered radioactivity and the values for iodinated calcitonin in plasma are those corrected for damage after chromatoelectrophoretic analysis. Concentration of radioactive HCT in plasma was calculated as the product of radioactivity in 1 ml of plasma, expressed in cpm, by the percentage of radioactivity remaining in the first 8 cm in the chromatoelectrophoretic system. The chromatoelectrophoresis of the inj ected or infused solution was performed immediately prior to injection and at the end of the infusion. 50 dul of solution was added to 2 ml of normal human plasma, and 100 Al of the mixture was submitted to chromatoelectrophoresis as a control for the amount of protein. MCR, defined as the volume of plasma which contains the amount of HCT irreversibly metabolized per min, was derived from both single injection and constant infusion studies. a) Single injection studies. The data of the disappearance curves expressed in fractions of the administered dose per liter of plasma described a nonlinear curve on semilog paper when plotted against time, indicating a multiexponential function. Theoretical curves of best fit were derived from the experimental data utilizing a computational program (8) difference between the experimental data and the corresponding points of the theoretical curve. When the program supplied several solutions, the solution containing the minimal number of exponentials necessary for a good fit was chosen. When the best theoretical curve was found to be the sum of three exponentials, Ae-at + Be-Pt + Ce-Yt, the metabolic clearance RESULTS Single injection studies. The damage of the labeled HCT was never above 15% of the hormonal radioactivity before the injection or the infusion. TCA precipitation was above 90% in all instances. The mean dis- * This subject is binephrectomized. He was studied successively by the two methods. t Indicates that the disappearance curve is fitted by the sum of two exponentials. § P < 0.01 when compared to the same values in normal subjects. Tables II and III , the values in both groups being slightly higher than those obtained from single injection studies. MCR of uremic subjects were again shown to be clearly lower than those of normal controls.
In vitro studies. The two degradation curves are both represented by monoexponentials as shown by the linear disappearance on semilog paper (Fig. 4) . The slope of the curve obtained with uremic plasma is lower than that obtained with normal plasma.
Recovery of radioactivity from urine. The time course of appearance of total radioactivity in urine after single intravenous injection of labeled hormone in normal subjects is shown in Fig. 5 . At the end of 48 hr, 95% of the total administered dose had been recovered. 2.4% of the urinary activity could be precipitated with TCA. In uremic hemodialysed subjects, most of the radioactivity was found in the dialysate.
DISCUSSION
The amount of human calcitonin injected can be considered as a tracer. About 0.16 tg was administered in the single injection studies. The fast initial volume of distribution of HCT represents as a mean 7.07% of the body weight in normal subjects (Table II) ever, if 2 ug/liter is considered a maximum value and if the actual concentration is on the order of three times less, the amount of injected HCT would still remain within a reasonable range. Chromatoelectrophoresis is held as an adequate method for estimating the pure radioactive polypeptide hor-'mones (7) , although it is possible that the last and slowest part of the disappearance curve may be modified in part by interference with iodinated degradation products. In these studies the percentage of activity remaining at the origin of the strip over the total activity decreased rapidly from more than 90% immediately prior to the injection to about 25% 3 hr later. The limit between the first radioactive peak corresponding to the active hormone and the second peak corresponding to damaged products was less clear cut in the later blood samples in each test. Thus, overestimates of 'I-HCT concentration could lead to underevaluation of the MCR.
Computational program supplied the theoretical curves of best fit to the experimental data. In 16 of 20 tests, a three exponential model provided the curve of best fit, and in the four remaining cases a two exponential model appeared to suffice. As it is difficult to describe the metabolism of HCT according to a three compartmental system in some subjects and a two compartmental one in others, we have preferred not to calculate the value of the different volumes and fluxes which are dependent on the exponential equation chosen. We calculated only MCR and volumes of fast initial distribution which could be estimated independently of these equations. The volume of distribution calculated in normal subjects is larger than the plasma volume. The same result has been found by West, O'Riordan, and Care (10) from single injection studies of pig calcitonin in the pig. We cannot provide a clear explanation of these high values which are at variance with the volume rather closer to plasma volume obtained in studies with other polypeptide hormones (3) . As the mean figure of MCR calculated from disappearance curves is valuable since it is very close to that obtained from constant infusion studies, it is possible that the distribution volumes calculated from the same curves are correct. If not, error might come from the binding of HCT to an intravascular protein. Leggate, Care, and Frazer (11) demonstrated that pig calcitonin was partly free and partly bound to a plasma protein. An hypothetic initial reversible binding of HCT to a protein which would migrate with albumin would explain an underevaluation of HCT concentration in plasma. On the other hand, if calcitonin diffuses very rapidly out of the intravascular space, it could also lead to underestimation of the actual value of the time zero intercept.
The determination of the MCR of a hormone by the use of an iodinated tracer administered by single injection is always controversial. It has been confirmed by many studies that injected unlabeled hormone or endogenous hormone have disappearance curves similar to those obtained using labeled hormones (12) (13) (14) although some discrepancies might have been found by other authors with different methods (15, 16 (22) , and of follicle stimulating hormone, 20 liters/ day (14) .
MCR of 'I-HCT can be divided into two parts, the first, possible degradation of active hormone by human plasma at body temperature as previously shown by Tashjian and Voelkel (23) , Milhaud and Hankiss (24) , and Maier, Nehar, Rittle, and Staehelin (25) , and the second, irreversible disappearance from the fast initial distribution compartment due to the utilization and degradation of HCT by different tissues. The degradation in plasma can be calculated by multiplying the slope of the degradation curve in vitro by the value of the plasma volume estimated to 4.5% of the body weight. Thus, the first component of MCR can be estimated to be 0.8 mV min for a normal subject weighing 70 kg. It represents a very low percentage of total MCR. As the percentage of 'I active hormone over total plasma radioactivity is much less in vivo than in vitro over any given period, it is likely that active hormone and damaged products have very different metabolic degradation rates in vivo, the disappearance from plasma of active hormone being much faster.
MCR is much lower in uremic than in normal subjects. The only binephrectomized patient had a MCR similar to those whose kidneys were present although nonfunctional. It may be concluded that the presence of kidneys in itself is not sufficient and that normal HCT degradation needs functioning kidneys. The decrease of MCR in these patients is likely to be the consequence of the nonutilization and/or the nondegradation of HCT by kidneys. Milhaud and Hankiss (24) have shown that HCT is rapidly destroyed' in vitro in the presence of kidney slices. The role of the kidney in the metabolism of 'Research standard B unit for thyroid calcitonin, Medical Research Council, London. most of the polypeptide hormones is now well established. MCR of human growth hormone is decreased in subjects with renal failure (20) . Fractional irreversible loss rate of insulin from plasma is also much lower in patients with end stage renal failure than in normal subjects (3). Half-life of parathormone is longer in a nephrectomy renal failure group than in control subjects (2) . In those studies (2, 3) , no difference was found between anephric patients and those with chronic renal failure. The aspect of renal function which is necessary for normal polypeptide hormone degradation is open to question. The decrease of the MCR of HCT in patients with renal failure could have functional consequences. HCT has the same effect as parathormone on phosphate and sodium renal excretion (18, 19) . Their reduced destruction would result in an increase in the phosphate and sodium loss per nephron, a major feature of the uremic kidney. HCT has an opposite effect to parathormone on bone resorption. The bone lesions of chronic renal failure are usually attributed to hyperparathyroidism. It is possible that the important individual discrepancies observed in patients with chronic renal disease might be due to variations of the balance between parathormone and calcitonin production and destruction. ACKNOWLEDGMENTS
